| Search | |
BioFact:
(1973) Stanley Cohen of Stanford University and Herbert Boyer of University of CA, San Francisco recombine ends of bacterial DNA after splicing a toad gene in between. They call their handiwork recombinant DNA, the press calls it genetic engineering.
ATC clean room constructors...validation guaranteed!
HemCon, Inc.
Vice President, Clinical Trials
HemCon, Inc. - Biotech Medical Device Company.
The remarkable HemCon bandage is designed to control severe bleeding and save lives. A remarkable concept in bandage design fabricated from a natural product derived from shrimp shells called chitosan. HemCon is currently seeking an experienced VP, Clinical Trials to plan, design and execute multiple full-scale clinical studies using human and animal subjects with investigational products.
The qualified individual will possess a BS preferably in a scientific discipline, 7-10 years in clinical trial management, expertise in medical device development and clinical laboratory operations. Experience within a FDA regulated industry with understanding and implementation of FDA regs.
For more information please contact our website at www.hemcon.com.
HemCon, Inc. is an Equal Opportunity Employer
Submitted: 03/20/2006
